TSS
NVAX icon

Two Sigma Securities’s Novavax NVAX Stock Holding History

Two Sigma Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-56,500
Closed -$2.91M – 2940
2022
Q2 		$2.91M Buy
56,500
+9,200
+19% +$477K 0.1% 221
2022
Q1 		$3.48M Buy
+47,300
New +$4.22M 0.12% 199
2021
Q4 		– Sell
-17,700
Closed -$3.67M – 1893
2021
Q3 		$3.67M Buy
17,700
+11,900
+205% +$2.62M 0.11% 158
2021
Q2 		$1.23M Buy
+5,800
New +$1.06M 0.04% 350

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Two Sigma Securities's NVAX Position: Q2 2026 in Review

Two Sigma Securities reduced its Novavax (NVAX) stake by 24% in Q2 2026, selling an estimated $29.7K and leaving 10,323 shares worth $97.2K. The position accounts for 0.01% of the portfolio, ranked #1305.

Two Sigma Securities first reported a position in NVAX in Q3 2016 and has held it in 12 quarters since. The position peaked at $1.36M in Q1 2022. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Two Sigma Securities held 10,323 shares of Novavax worth $97.2K as of Q2 2026.
  • Two Sigma Securities sold 3,316 Novavax shares in Q2 2026, an estimated $29.7K.
  • Novavax made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1305 holding.
  • Two Sigma Securities first reported a position in Novavax in Q3 2016 and has held it in 12 quarters since.
  • Two Sigma Securities's Novavax position peaked at $1.36M in Q1 2022.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.